Pharmaceutical giant Pfizer and others have announced that they have begun procedures to obtain formal approval in addition to the current emergency use authorization in the United States for the new coronavirus vaccine.
If officially approved, you will be able to inoculate even after the emergency is lifted.
The new coronavirus vaccine developed by Pfizer in the United States and BioNTech in Germany is currently being vaccinated in the United States under the permission of "emergency use", which is specially issued in the event of a public health emergency.
Regarding this, Pfizer and others announced on the 7th that they have started the application procedure for formal approval.
Once officially approved, vaccination will be possible even after the emergency declaration, which is a prerequisite for an emergency use authorization, has been lifted, and BioNTech CEO Uglu Sahin said, "This application achieves long-term herd immunity. It will be an important foundation for the containment of the new coronavirus. "
Formal approval will also make it easier for schools and businesses to require students and employees to receive vaccinations.
The formal approval review takes longer than the emergency use authorization and may take more than a year, but Pfizer and others are requesting priority review this time.